Down-regulation of miR-223 reverses epithelial-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells-Reference-Cited by-同舟云学术

Down-regulation of miR-223 reverses epithelial-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells

Published:2015-01-30 Issue:3 Volume:6 Page:1740-1749
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Ma Jia¹²,Fang Binbin³,Zeng Fanpeng³,Ma Cong³,Pang Haijie³,Cheng Long⁴,Shi Ying²,Wang Hui³,Yin Bin¹,Xia Jun²,Wang Zhiwei¹

Affiliation:

1. The Cyrus Tang Hematology Center and Collaborative Innovation Center of Hematology, Jiangsu Institute of Hematology, The First Affiliated Hospital, Soochow University, Suzhou 215123, China

2. Department of Biochemistry and Molecular Biology, Bengbu Medical College, Anhui 233030, China

3. Research Center of Clinical Laboratory Science, Bengbu Medical College, Anhui 233030, China

4. Department of Clinical Laboratory, Yijishan Hospital, Wannan Medical College, Wuhu 241000, Anhui, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Using microRNAs Networks to Understand Pancreatic Cancer—A Literature Review;Biomedicines;2024-08-01

2. MiR-223-3p in Cancer Development and Cancer Drug Resistance: Same Coin, Different Faces;International Journal of Molecular Sciences;2024-07-26

3. Extracellular Vesicular miRNA in Pancreatic Cancer: From Lab to Therapy;Cancers;2024-06-08

4. Microbiome and MicroRNA or Long Non-Coding RNA—Two Modern Approaches to Understanding Pancreatic Ductal Adenocarcinoma;Journal of Clinical Medicine;2023-08-30

5. Nanoparticle-Mediated Therapy with miR-198 Sensitizes Pancreatic Cancer to Gemcitabine Treatment through Downregulation of VCP-Mediated Autophagy;Pharmaceutics;2023-07-28